News Daily News Half of Patients Stop Semaglutide for Weight Loss by 1 Year Todd Neale September 18, 2025
News Daily News AI-Supported Coaching Shows Promise for Improving Glycemic Control L.A. McKeown August 25, 2025
News Daily News Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity L.A. McKeown August 07, 2025
News Daily News PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors Michael O'Riordan July 18, 2025
News Daily News PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes Todd Neale July 14, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations L.A. McKeown January 31, 2025
News Daily News Misleading Statements Common in Online Ads for Compounded GLP-1s L.A. McKeown January 20, 2025
News Daily News Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key Todd Neale November 13, 2024
News Daily News Liraglutide Helps Shed Weight in Young Children With Obesity Todd Neale September 13, 2024
News Daily News Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says Caitlin E. Cox August 28, 2024
News Daily News Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide Yael L. Maxwell July 10, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose L.A. McKeown December 01, 2023
News Daily News Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts Michael O'Riordan September 08, 2023